Cancer (Oncology)
Cancer (Oncology)
Herduo 250® Lapatinib Tablets
Lapatinib 250mg
- Composition
- Lapatinib 250mg
- Dosage form
- Tablet
- Pack size
- Bottle of 30 Tablet
- Manufacturer
- Natco
- Also known as
- Tykerb
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Herduo 250 mg contains lapatinib, a targeted anticancer medicine used to treat certain types of HER2-positive breast cancer, including advanced or metastatic disease. It inhibits HER2 and EGFR tyrosine kinase signalling, helping slow cancer cell growth
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Licensed wholesalerForm 20B & 21B, Delhi
Discreet packagingPlain outer box, no product labels
Worldwide shippingDirect to you or your customer
Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Fulviglen 250® Fulvestrant Injection
Fulvestrant 250mg
Injection · Prefilled Synringe of 5ml Injection